BSE Demat Auction list for Settlement No. 796 dated January 13, 2026, listing securities and quantities subject to auction.
Impact
Medium
Severity
Medium
Justification
Routine demat auction affecting multiple securities due to delivery failures in settlement 796. Impacts specific brokers and clients with shortages but is a standard market mechanism.
BSE announces demat auction for settlement number 796 involving 109 securities across various companies with pending delivery obligations.
Impact
Medium
Severity
Medium
Justification
Routine demat auction for settlement obligations affecting multiple securities with varying quantities, operational impact on specific trading members and clients with pending deliveries
BSE publishes list of securities and quantities for demat auction settlement number 796 covering 87 scrips across various companies.
Impact
Medium
Severity
Medium
Justification
Routine demat auction settlement notification affecting 87 scrips. Important for brokers and clearing members to fulfill delivery obligations but represents standard market operations.
BSE demat auction listing for settlement number 784 covering 103 securities across various scrips with specified quantities for auction.
Impact
Medium
Severity
Medium
Justification
Regular demat auction notice affecting 103 securities with specified quantities. Important for settlement participants and brokers handling these specific scrips but routine market operation.
BSE demat auction listing 105 scrips with their respective quantities for settlement number 784 dated December 26, 2025.
Impact
Medium
Severity
Medium
Justification
Standard demat auction for settlement obligations affecting 105 scrips. Medium impact as it involves delivery failures requiring auction settlement, but is a regular operational process.
BSE demat auction settlement for delivery shortages across 130 scrips with quantities ranging from 1 to 50,000 shares.
Impact
Low
Severity
Low
Justification
Routine demat auction for settlement of delivery shortages; standard market operations procedure affecting specific scrips with limited market-wide impact